Which companies discussed China Exposure in Health Care in earnings calls?

645 companies mentioned china exposure across 1,507 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Merck KGaA (18 calls), Bio-Techne Corporation (16 calls), Revvity, Inc. (15 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning China Exposure
2024Q3328
2024Q4367
2025Q1457
2025Q2389
2025Q3412
2025Q4342
2026Q1419
2026Q2332
2026Q38

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Merck KGaA MRK Health Care 18 Jun 9, 2026
Bio-Techne Corporation TECH Health Care 16 May 12, 2026
Revvity, Inc. RVTY Health Care 15 Jun 9, 2026
Align Technology, Inc. ALGN Health Care 14 Jun 8, 2026
Repligen Corporation RGEN Health Care 14 Jun 3, 2026
Royalty Pharma plc RPRX Health Care 13 Jun 9, 2026
Charles River Laboratories International, Inc. CRL Health Care 13 Jun 3, 2026
Qiagen N.V. QGEN Health Care 12 May 12, 2026
Summit Therapeutics Inc. SMMT Health Care 11 Jun 8, 2026
Pfizer Inc. PFE Health Care 11 Jun 8, 2026
Cytokinetics, Incorporated CYTK Health Care 11 Jun 8, 2026
GE HealthCare Technologies Inc. GEHC Health Care 11 Jun 3, 2026
Eli Lilly and Company LLY Health Care 10 Jun 9, 2026
Johnson & Johnson JNJ Health Care 9 Jul 15, 2026
GSK plc GSK Health Care 9 Jun 9, 2026
Waters Corporation WAT Health Care 9 Jun 3, 2026
Agilent Technologies, Inc. A Health Care 9 Jun 3, 2026
Viatris Inc. VTRS Health Care 9 May 12, 2026
Vertex Pharmaceuticals Incorporated VRTX Health Care 8 Jun 10, 2026
BeOne Medicines AG ONC Health Care 8 Jun 8, 2026
Haleon plc HLN Health Care 8 Jun 3, 2026
Nuvation Bio Inc. NUVB Health Care 8 May 26, 2026
Bausch Health Companies Inc. BHC Health Care 8 May 20, 2026
Thermo Fisher Scientific Inc. TMO Health Care 8 May 20, 2026
Mettler-Toledo International Inc. MTD Health Care 8 May 13, 2026
Zai Lab Limited ZLAB Health Care 8 May 7, 2026
Lyell Immunopharma, Inc. LYEL Health Care 7 Jun 8, 2026
Merit Medical Systems, Inc. MMSI Health Care 7 Jun 8, 2026
Bruker Corporation BRKR Health Care 7 Jun 4, 2026
Astellas Pharma Inc. 4503 Health Care 7 Jun 3, 2026
Bio-Rad Laboratories, Inc. BIO Health Care 7 Jun 3, 2026
Bausch + Lomb Corporation BLCO Health Care 7 Jun 1, 2026
Boston Scientific Corporation BSX Health Care 7 May 27, 2026
Danaher Corporation DHR Health Care 7 May 13, 2026
Becton, Dickinson and Company BDX Health Care 7 May 12, 2026
Cytek Biosciences, Inc. CTKB Health Care 7 May 7, 2026
Illumina, Inc. ILMN Health Care 7 Apr 30, 2026
Zimmer Biomet Holdings, Inc. ZBH Health Care 7 Apr 28, 2026
Telix Pharmaceuticals Limited TLX Health Care 7 Mar 17, 2026
Penumbra, Inc. PEN Health Care 7 Jan 12, 2026
AstraZeneca PLC AZN Health Care 6 Jul 6, 2026
Arrowhead Pharmaceuticals, Inc. ARWR Health Care 6 Jun 29, 2026
Corvus Pharmaceuticals, Inc. CRVS Health Care 6 Jun 8, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 6 Jun 8, 2026
Elanco Animal Health Incorporated ELAN Health Care 6 Jun 2, 2026
Embecta Corp. EMBC Health Care 6 May 13, 2026
Belite Bio, Inc BLTE Health Care 6 May 13, 2026
Pacific Biosciences of California, Inc. PACB Health Care 6 May 7, 2026
LivaNova PLC LIVN Health Care 6 May 6, 2026
Envista Holdings Corporation NVST Health Care 6 May 6, 2026

Representative quotes

…core lab business, listen, our businesses have performed very well across the world. We obviously had the challenge of the VBP in China, where we had a pretty sizable portion of our international business declined for at least 5 quarters, around 30%. We're still forecasting a decline…
Abbott Laboratories (ABT), July 16, 2026. Read the full transcript →
…regularly closed. So even shifting growth into the region is a challenge. In the APAC region, which I recently visited myself, we -- in China, we see that IVF cycles are declining year-over-year. This trend is expected to continue based on population demographics. The Southeast Asia within…
Vitrolife AB (publ) (VITR), July 16, 2026. Read the full transcript →
…constant currency basis at last year's exchange rates would have given us an increase of 14% to GBP 91 million. China increased 5% in the year, which was a pleasing performance. And that would have been 9% on a constant currency basis. Again, the Chinese…
ECO Animal Health Group plc (EAH), July 16, 2026. Read the full transcript →
…driven by procedure growth, commercial execution, and new product performance, partially offset by competitive PFA pressures. There was also a negative impact from China inventory, which we estimate to be 400 basis points. Abiomed saw a decline of 2% due to pressures on U.S. procedures driven by usage…
Johnson & Johnson (JNJ), July 15, 2026. Read the full transcript →

Frequently asked questions

What is China Exposure and why are companies discussing it?

Demand, competition and geopolitical risk in China as management teams weigh exposure to the world's second-largest economy.

Which company mentioned china exposure most in Health Care in the past year?

Merck KGaA (MRK) led with 18 calls referencing china exposure, most recently on June 9, 2026.

How can I track china exposure mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related macro themes

Last updated: July 16, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (China, china, chinese market). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.